| abstract |
The invention relates to a therapeutical composition of matter for the treatment by perfusion of shock states comprising as an essential ingredient therein, an effective amount either, of a compound of the formula: <IMAGE> wherein R1 and R4 stant for H or CH3 or C2H5, R2 stands for H or NO2 and R3 stands for NHR4 or CH3 or C2H5 alone or of a mixture of said compound with a cyclooxygenase blocker. |